<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2011</study_start_year><condition>Neoplasm Metastasis</condition><condition>Neoplasms, Second Primary</condition><condition>Colorectal cancer</condition><condition>Colorectal Neoplasms</condition><condition>Colorectal Liver Metastases</condition><disease>Neoplasm Metastasis</disease><disease>Neoplasms, Second Primary</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Colorectal Liver Metastases</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2103992</full_dataset_link><location>United Kingdom</location><location>France</location><location>Germany</location><study_start_month>1</study_start_month><keyword>Liver metastases</keyword><keyword>Colorectal adenocarcinoma</keyword><keyword>Accuray</keyword><keyword>Hepatic metastases</keyword><keyword>CyberKnife</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>CyberKnife for Hepatic Metastases From Colorectal Cancer</name><description>This prospective, multicenter study is intended to establish the efficacy and toxicity of treating unresectable colorectal liver metastases with accurately administered radiation using the CyberKnife stereotactic radiosurgery system.</description><dates><creation>2011-01-15</creation></dates><accession>2103992</accession><cross_references><ClinicalTrials___gov>NCT01318447</ClinicalTrials___gov></cross_references></HashMap>